Article Data

  • Views 537
  • Dowloads 148

Case Reports

Open Access

Pelvic myeloid sarcoma: a multidisciplinary approach

  • R. Seracchioli1
  • E. Geraci1,*,
  • R. Paradisi1
  • G. Montanari1
  • L. Zannoni1
  • V. Tabanelli2
  • S.A. Pileri2
  • S. Carloni3
  • C. Sartor4
  • G. Martinelli4

1Department of Gynecology and Physiopathology of Human Reproduction, DIMEC, S. Orsola Hospital, University of Bologna, Bologna, Italy

2Unit of Hematopathology, European Institute of Oncology, 20141 Milan, Italy

3Hematology Lab IRCCS Istituto Scientifico Romagnolo per la Cura e lo Studio dei Tumori (I.R:S.T.) S.r.l., Meldola, FC

4Department of Hematology/Oncology L. e A. Seragnoli, Hematopathology and Haematology Sections, DIMES, S. Orsola Hospital, University of Bologna, Bologna, Italy

DOI: 10.12892/ejgo3683.2017 Vol.38,Issue 3,June 2017 pp.476-478

Published: 10 June 2017

*Corresponding Author(s): E. Geraci E-mail: ely.200@hotmail.it

Abstract

Myeloid sarcoma (MS) is a rare tumor mass derived from the extramedullary proliferation of blasts of one or more of myeloid lineages. It usually occurs at an anatomical site other than the bone marrow (BM). Among the anatomical site which may be involved, female genital tract is a rare localization. When MS follows a previous history of myeloid pathology it is usually associated to a poor prognosis. To date this disease was managed with exploratory laparotomy or with surgical debulking. The authors report a case of laparoscopic diagnosis of a pelvic myeloid sarcoma in a patient previously affected by acute myeloid leukemia, evidencing the importance of minimally invasive diagnosis and subsequent multidisciplinary management.

Keywords

Myeloid sarcoma; Laparoscopy; Multidisciplinary approach; Pelvic mass; Extramedullary sarcoma.

Cite and Share

R. Seracchioli,E. Geraci,R. Paradisi,G. Montanari,L. Zannoni,V. Tabanelli,S.A. Pileri,S. Carloni,C. Sartor,G. Martinelli. Pelvic myeloid sarcoma: a multidisciplinary approach. European Journal of Gynaecological Oncology. 2017. 38(3);476-478.

References

[1] Garcia M.G., Deavers M.T., Knoblock R.J., Chen W., Tsimberidou A.M., Manning J.T., Medeiros L.J.: “Myeloid sarcoma involving the gynecologic tract: a report of 11 cases and review of the literature”. Am. J. Clin. Pathol., 2006, 125, 783.

[2] Pitz M.W., Maslyak O., Morales C., Seftel M.D.: “Myeloid sarcoma of the uterus presenting as vaginal bleeding”. Intern. Med. J., 2006, 36, 669.

[3] Usmani S.Z., Shahid Z., Saleh H., Nasser K.A.: “Myeloid sarcoma presenting with acute renal failure and bilateral ureteral obstruction: a case report and review of the literature”. Am. J. Med. Sci., 2007, 334, 136.

[4] Yoshihara S., Ando T., Ogawa H.: “Extramedullary relapse of acute myeloid leukemia after allogeneic hematopoietic stem cell transplantation: an easily overlooked but significant pattern of relapse”. Biol. Blood Marrow Transplant., 2012, 18, 1800.

[5] Medeiros L.R., Rosa D.D., Bozzetti M.C., Fachel J.M., Furness S., Garry R., et al.: “Laparoscopy versus laparotomy for benign ovarian tumour”. Cochrane Database Syst. Rev., 2009, 15.

[6] Harris A.C., Kitko C.L., Couriel D.R., Braun T.M., Choi S.W., Magenau J., et al.: “Extramedullary relapse of acute myeloid leukemia following allogenic hematopoietic stem cell transplantation: incidence, risk factors and outcomes”. Haematologica, 2006, 98, 179.

[7] Pavletic S.Z., Kumar S., Mohty M., De Lima M., Foran J.M., Pasquini M., et al.: “NCI First International Workshop on the Biology, Prevention, and Treatment of Relapse after allogenic hematopoietic stem cell transplantation: report from the committee on the epidemiology and natural history of relapse following allogenic cell transplantation”. Biol. Blood Marrow Transplant., 2010, 16, 871.

[8] Padilla L.A., Radosevich D.M., Milad M.P.: “Limitations of the pelvic examination for evaluation of the female pelvic organs”. Int. J. Gynaecol. Obstet., 2005, 88, 84.

[9] Jung J.Y., Jung M.J., Oh J.Y., Kim M.H., Yun H.G., Oh L.Y., et al.: “Primary granulocytic sarcoma of ovary: A rare case report”. J. Womens Med., 2010, 3, 81.

[10] Avni B., Koren-Michowitz M.: “Myeloid sarcoma: current approach and therapeutic options”. Ther. Adv. Hematol., 2011, 2, 309.

Abstracted / indexed in

Science Citation Index Expanded (SciSearch) Created as SCI in 1964, Science Citation Index Expanded now indexes over 9,500 of the world’s most impactful journals across 178 scientific disciplines. More than 53 million records and 1.18 billion cited references date back from 1900 to present.

Biological Abstracts Easily discover critical journal coverage of the life sciences with Biological Abstracts, produced by the Web of Science Group, with topics ranging from botany to microbiology to pharmacology. Including BIOSIS indexing and MeSH terms, specialized indexing in Biological Abstracts helps you to discover more accurate, context-sensitive results.

Google Scholar Google Scholar is a freely accessible web search engine that indexes the full text or metadata of scholarly literature across an array of publishing formats and disciplines.

JournalSeek Genamics JournalSeek is the largest completely categorized database of freely available journal information available on the internet. The database presently contains 39226 titles. Journal information includes the description (aims and scope), journal abbreviation, journal homepage link, subject category and ISSN.

Current Contents - Clinical Medicine Current Contents - Clinical Medicine provides easy access to complete tables of contents, abstracts, bibliographic information and all other significant items in recently published issues from over 1,000 leading journals in clinical medicine.

BIOSIS Previews BIOSIS Previews is an English-language, bibliographic database service, with abstracts and citation indexing. It is part of Clarivate Analytics Web of Science suite. BIOSIS Previews indexes data from 1926 to the present.

Journal Citation Reports/Science Edition Journal Citation Reports/Science Edition aims to evaluate a journal’s value from multiple perspectives including the journal impact factor, descriptive data about a journal’s open access content as well as contributing authors, and provide readers a transparent and publisher-neutral data & statistics information about the journal.

Submission Turnaround Time

Conferences

Top